Drugs - Drugs Xagena

Drugs

Home Page

Xagena Medicine

Xagena.net

Tequin associated with hypoglycemia and hyperglycemia

Hepatotoxity linked to Tracleer

Mobic linked to higher risk of adverse cardiovascular events than Celebrex and Vioxx

Paroxetine: increased risk of suicidal behavior in young adults

FDA has approved Chantix for smoking cessation

Azilect, a new treatment for Parkinson's Disease

Evista associated with increased risk of stroke mortality in postmenopausal women at increased risk for cardiovascular disease

FDA has approved Ranexa for chronic angina

FDA extends prophylaxis indication for Tamiflu to children between 1 to 12 years of age

Hearing loss from chemotherapy underestimated

Beethoven suffered from a toxic overload of lead

Some patients who receive an appropriate level of Morphine live a little longer

Acetaminophen poisoning, the most common cause of acute liver failure in the United States

Use of gastric acid-suppressive agents linked with increased risk for diarrhea infection

iNOS-based inflammation pathway is cross-linked with COX-2 pathway

Epogen: reports of pure red cell aplasia and severe anemia associated with neutralizing antibodies to erythropoietin

NovoSeven: increased risk of arterial thromboembolic events in elderly, non-hemophiliac, intracerebral hemorrhage patients

Risk of birth defects with Paxil

Three myocardial infarctions with Vioxx were not included in VIGOR study

EMEA has approved Revatio for the treatment of pulmonary arterial hypertension

Aranesp: pure red cell aplasia and severe anemia associated with neutralizing antibodies

FDA drug prescribing warnings: physicians' compliance with the recommendations of the BBWs was highly variable

No connection between increased belly fat and decreased limb fat in men who take antiretrovirals

Statins suspected of being associated with memory loss

Amoxicillin use during infancy may be linked to tooth enamel defects

Statin therapy can reduce the incidence of major coronary events and stroke

Low-dose Aspirin might prevent the cardiac damage of Cox-2 inhibitors

FDA has approved Tarceva in combination with Gemcitabine for advanced, inoperable or metastatic pancreatic cancer

Growth hormone illegal for off-label anti-aging use

Muraglitazar increases the risk for morbidity and mortality in diabetic patients

Next Pages 1 2 3 4 5 6 7 [8] 9 10

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions